There was a suggestion for increased premenopausal breast cancer risk for taller BRCA1 and BRCA2 variant carriers, but the association was not significant (HR 1.19 per 10 cm increase, 95% CI 0.91–1.56 and HR 1.32, 95% CI 0.92–1.90, respectively). Here, BRCA2 is linked to breast carcinoma.